Categories AlphaGraphs, Earnings, Energy

Infographic: A snapshot of Chevron’s (CVX) Q3 2022 earnings results

Chevron Corporation (NYSE: CVX) reported a sharp increase in net profit for the third quarter of 2022 when the energy giant’s revenues jumped around 50%. Both earnings and the top line exceeded the consensus estimates.

Total revenues and other income rose sharply to $66.6 billion in the September quarter and came in above analysts’ forecast. Revenues benefited from strong growth in crude oil prices.

Reflecting the positive top-line performance, third-quarter adjusted profit moved up to $5.56 per share from $2.96 per share in the same period of 2021. Unadjusted profit rose to $11.23 billion or $5.78 per share from $6.11 billion or $3.19 per share last year. Earnings also beat the estimates.


Check this space to read management/analysts’ comments on Chevron’s Q3 results


“We delivered another quarter of strong financial performance with return on capital employed of 25 percent. At the same time, we’re increasing investments and growing energy supplies, with our Permian production reaching another quarterly record,” said Chevron’s CEO Mike Wirth.

Prior Performance

  • Chevron Q2 2022 earnings infographic
  • Chevron Q1 2022 earnings infographic

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal

Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities

Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close